Research Article
Evolution of Orofacial Symptoms and Disease Progression in Idiopathic Parkinson’s Disease: Longitudinal Data from the Jönköping Parkinson Registry
Table 1
Baseline, demographic, and clinical characteristics of the study population with idiopathic Parkinson’s disease (IPD) (
).
| Characteristic | Value |
| Sex-male (%) | 61.5% | Age (at baseline) (yr) mean (SD) | 64.7 (9.9) | Disease duration (yr) mean (SD) | 6.6 (5.5) | Follow-up time (yr) mean (SD) | 3.5 (2.9) | Baseline symptoms (%) | | Resting tremor | 76.9% | Bradykinesia | 73.4% | Rigidity | 76.2% | Fall | 18.2% | Freezing | 13.3% | Dyskinesia | 23.8% | Wearing off | 14.7% | Postural instability | 8.4% | Visual impairment | 19.6% | Hyposmia | 9.1% | Urinary urgency | 21.7% | Orthostatic hypotension | 12.6% | Voice changes | 16.8% | Depression | 18.2% | UPDRS score (at baseline) mean (SD) | | Part I | 0.8 (1.3) | Part II | 9.3 (5.0) | Part III | 21.7 (12.3) | Part IV | 0.5 (1.7) | Total | 32.3 (15.0) | Type of medication (%) | | Levodopa | 85.3% | Dopamine agonist | 49.2% | MAO-B inhibitor | 13.2% | Other dopaminergics | 5.6% | Orofacial symptoms (during follow-up) (%) | | Drooling | 55.3% | Speech problems | 65.5% | Swallowing difficulties | 34.5% | Facial expression | 91.6% |
|
|
SD: standard deviation; UPDRS: Unified Parkinson’s Disease Rating Scale.
|